K984530

Substantially Equivalent

DRX NTX OR, OSTEOMARK NTX DIRECT RESPONSE

Applicant: Metrika, Inc.
Product code: JFY
Advisory panel: Clinical Chemistry
Date received: 1998-12-21
Decision date: 1999-08-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Los Angeles, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.